Inhaled antibiotics in cystic fibrosis: what's new?
作者信息
Hewer Simon Langton
机构信息
Bristol Royal Hospital for Children, Upper Maudlin Street, Bristol BS2 8BJ, UK.
出版信息
J R Soc Med. 2012 Jun;105 Suppl 2(Suppl 2):S19-24. doi: 10.1258/jrsm.2012.12s004.
Abstract
摘要
相似文献
1
Inhaled antibiotics in cystic fibrosis: what's new?囊性纤维化患者吸入用抗生素：有哪些新进展？
J R Soc Med. 2012 Jun;105 Suppl 2(Suppl 2):S19-24. doi: 10.1258/jrsm.2012.12s004.
2
Aerosolized antibiotics in cystic fibrosis: an update.囊性纤维化中的雾化抗生素：最新进展
Expert Rev Respir Med. 2014 Jun;8(3):305-14. doi: 10.1586/17476348.2014.896205.
3
Inhaled antibiotics.吸入性抗生素
Pediatr Pulmonol Suppl. 2004;26:92-4. doi: 10.1002/ppul.70065.
4
Open label study of inhaled aztreonam for Pseudomonas eradication in children with cystic fibrosis: The ALPINE study.吸入性阿托莫兰治疗囊性纤维化患儿铜绿假单胞菌清除的开放性研究：ALPINE 研究。
J Cyst Fibros. 2015 Jan;14(1):111-9. doi: 10.1016/j.jcf.2014.06.003. Epub 2014 Aug 1.
5
Inhaled aztreonam lysine versus inhaled tobramycin in cystic fibrosis. An economic evaluation.吸入用氨曲南赖氨酸与吸入用妥布霉素治疗囊性纤维化的经济学评价
Ann Am Thorac Soc. 2015 Jul;12(7):1030-8. doi: 10.1513/AnnalsATS.201312-453OC.
6
[Use of inhaled tobramycin in patients with cystic fibrosis].吸入用妥布霉素在囊性纤维化患者中的应用
Ter Arkh. 2010;82(8):76-8.
7
Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.吸入性抗生素用于囊性纤维化患者的肺部急性加重期
Cochrane Database Syst Rev. 2012 Dec 12;12:CD008319. doi: 10.1002/14651858.CD008319.pub2.
8
Novel inhaled combined antibiotic formulations in the treatment of Pseudomonas aeruginosa airways infections in cystic fibrosis.新型吸入性联合抗生素制剂治疗囊性纤维化患者铜绿假单胞菌气道感染
Expert Rev Anti Infect Ther. 2015 Jul;13(7):897-905. doi: 10.1586/14787210.2015.1041925. Epub 2015 Apr 28.
9
Intravenous versus oral antibiotics for eradication of Pseudomonas aeruginosa in cystic fibrosis (TORPEDO-CF): a randomised controlled trial.静脉注射与口服抗生素治疗囊性纤维化患者铜绿假单胞菌感染的疗效比较（TORPEDO-CF）：一项随机对照试验。
Lancet Respir Med. 2020 Oct;8(10):975-986. doi: 10.1016/S2213-2600(20)30331-3.
10
Factors affecting the incidence of Stenotrophomonas maltophilia isolation in cystic fibrosis.影响囊性纤维化患者嗜麦芽窄食单胞菌分离率的因素。
Chest. 2002 Jun;121(6):1754-60. doi: 10.1378/chest.121.6.1754.
引用本文的文献
1
Profiling cell envelope-antibiotic interactions reveals vulnerabilities to β-lactams in a multidrug-resistant bacterium.分析细胞包膜-抗生素相互作用揭示了多药耐药菌对β-内酰胺类抗生素的敏感性。
Nat Commun. 2023 Aug 9;14(1):4815. doi: 10.1038/s41467-023-40494-5.
2
New Therapeutic Approaches in Cystic Fibrosis.囊性纤维化的新治疗方法
Turk J Pharm Sci. 2020 Dec 23;17(6):686-697. doi: 10.4274/tjps.galenos.2020.76401.
3
The Antibacterial and Anti-inflammatory Activity of Chicken Cathelicidin-2 combined with Exogenous Surfactant for the Treatment of Cystic Fibrosis-Associated Pathogens.鸡 cathelicidin-2 联合外源性表面活性剂的抗细菌和抗炎活性用于治疗囊性纤维化相关病原体。
Sci Rep. 2017 Nov 14;7(1):15545. doi: 10.1038/s41598-017-15558-4.
4
Current and future treatment options for cystic fibrosis lung disease: latest evidence and clinical implications.囊性纤维化肺病的当前及未来治疗选择：最新证据与临床意义
Ther Adv Chronic Dis. 2016 May;7(3):170-83. doi: 10.1177/2040622316641352. Epub 2016 May 1.
5
Biopharmaceutical characterization of nebulized antimicrobial agents in rats: 2. Colistin.大鼠雾化抗菌剂的生物制药特性：2. 黏菌素
Antimicrob Agents Chemother. 2014 Jul;58(7):3950-6. doi: 10.1128/AAC.02819-14. Epub 2014 May 5.
6
Biopharmaceutical characterization of nebulized antimicrobial agents in rats: 1. Ciprofloxacin, moxifloxacin, and grepafloxacin.大鼠雾化抗菌剂的生物制药特性：1. 环丙沙星、莫西沙星和格帕沙星。
Antimicrob Agents Chemother. 2014 Jul;58(7):3942-9. doi: 10.1128/AAC.02818-14. Epub 2014 May 5.
7
Population pharmacokinetics of colistin methanesulfonate in rats: achieving sustained lung concentrations of colistin for targeting respiratory infections.多黏菌素甲磺酸盐在大鼠体内的群体药代动力学研究：实现多黏菌素在肺部的持续浓度以靶向治疗呼吸道感染。
Antimicrob Agents Chemother. 2013 Oct;57(10):5087-95. doi: 10.1128/AAC.01127-13. Epub 2013 Aug 5.
本文引用的文献
1
Aztreonam (for inhalation solution) for the treatment of chronic lung infections in patients with cystic fibrosis: an evidence-based review.氨曲南（吸入溶液）用于治疗囊性纤维化患者的慢性肺部感染：一项循证综述
Core Evid. 2011;6:59-66. doi: 10.2147/CE.S11181. Epub 2011 Aug 11.
2
Aztreonam for inhalation solution (AZLI) in patients with cystic fibrosis, mild lung impairment, and P. aeruginosa.AZLI（注射用氨曲南）在囊性纤维化、轻度肺损伤和铜绿假单胞菌感染的患者中的应用。
J Cyst Fibros. 2011 Jul;10(4):234-42. doi: 10.1016/j.jcf.2011.02.007. Epub 2011 Mar 26.
3
Accurate assessment of adherence: self-report and clinician report vs electronic monitoring of nebulizers.准确评估依从性：自我报告和临床医生报告与雾化器电子监测的比较。
Chest. 2011 Aug;140(2):425-432. doi: 10.1378/chest.09-3074. Epub 2011 Feb 17.
4
Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: The EAGER trial.妥布霉素吸入粉在囊性纤维化患者中的安全性、疗效和便利性：EAGER 试验。
J Cyst Fibros. 2011 Jan;10(1):54-61. doi: 10.1016/j.jcf.2010.10.003. Epub 2010 Nov 12.
5
Tobramycin inhalation powder for P. aeruginosa infection in cystic fibrosis: the EVOLVE trial.妥布霉素吸入粉用于囊性纤维化患者铜绿假单胞菌感染：EVOLVE试验
Pediatr Pulmonol. 2011 Mar;46(3):230-8. doi: 10.1002/ppul.21356. Epub 2010 Oct 20.
6
An 18-month study of the safety and efficacy of repeated courses of inhaled aztreonam lysine in cystic fibrosis.一项为期 18 个月的研究，旨在评估重复使用吸入性阿佐霉素赖氨酸治疗囊性纤维化的安全性和疗效。
Pediatr Pulmonol. 2010 Nov;45(11):1121-34. doi: 10.1002/ppul.21301.
7
Baseline characteristics and factors associated with nutritional and pulmonary status at enrollment in the cystic fibrosis EPIC observational cohort.基线特征及与纳入囊性纤维化 EPIC 观察队列时营养和肺部状况相关的因素。
Pediatr Pulmonol. 2010 Sep;45(9):934-44. doi: 10.1002/ppul.21279.
8
Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis: the ELITE trial.囊性纤维化患者早期铜绿假单胞菌感染的治疗：ELITE 试验。
Thorax. 2010 Apr;65(4):286-91. doi: 10.1136/thx.2009.121657. Epub 2009 Dec 8.
9
Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.根除囊性纤维化患者体内铜绿假单胞菌的抗生素策略。
Cochrane Database Syst Rev. 2009 Oct 7(4):CD004197. doi: 10.1002/14651858.CD004197.pub3.
10
Early anti-pseudomonal acquisition in young patients with cystic fibrosis: rationale and design of the EPIC clinical trial and observational study'.早期抗假单胞菌在年轻囊性纤维化患者中的获得：EPIC 临床试验和观察研究的原理和设计'。
Contemp Clin Trials. 2009 May;30(3):256-68. doi: 10.1016/j.cct.2009.01.003. Epub 2009 Jan 15.
Zotero 插件